Primoris Wealth Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Buy
141,009
+1,809
+1% +$72.9K 2.97% 7
2026
Q1
$4.61M Sell
139,200
-200
-0.1% -$6.5K 3.23% 9
2025
Q4
$4.56M Sell
139,400
-3,660
-3% -$90K 2.73% 12
2025
Q3
$2.55M Buy
143,060
+127,360
+811% +$1.85M 1.62% 21
2025
Q2
$170K Buy
15,700
+1,300
+9% +$17K 0.12% 96
2025
Q1
$277K Hold
14,400
0.21% 78
2024
Q4
$237K Sell
14,400
-350
-2% -$4.96K 0.18% 82
2024
Q3
$207K Buy
+14,750
New +$163K 0.15% 97

Other funds holding AXGN

Primoris Wealth Advisors's AXGN Position: Q2 2026 in Review

Primoris Wealth Advisors increased its Axogen (AXGN) stake by 1.3% in Q2 2026, buying an estimated $72.9K and bringing the position to 141,009 shares worth $6.51M. The position accounts for 2.97% of the portfolio, ranked #7.

Primoris Wealth Advisors first reported a position in AXGN in Q3 2024 and has held it in 8 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Primoris Wealth Advisors held 141,009 shares of Axogen worth $6.51M as of Q2 2026.
  • Primoris Wealth Advisors bought 1,809 Axogen shares in Q2 2026, an estimated $72.9K.
  • Axogen made up 2.97% of Primoris Wealth Advisors's portfolio in Q2 2026, its #7 holding.
  • Primoris Wealth Advisors first reported a position in Axogen in Q3 2024 and has held it in 8 quarters since.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Primoris Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.